WO2012141576A1 - Procédé d'examen de défauts du champ de vision - Google Patents

Procédé d'examen de défauts du champ de vision Download PDF

Info

Publication number
WO2012141576A1
WO2012141576A1 PCT/NL2011/050260 NL2011050260W WO2012141576A1 WO 2012141576 A1 WO2012141576 A1 WO 2012141576A1 NL 2011050260 W NL2011050260 W NL 2011050260W WO 2012141576 A1 WO2012141576 A1 WO 2012141576A1
Authority
WO
WIPO (PCT)
Prior art keywords
visual
eye
stimulus
patient
sequence
Prior art date
Application number
PCT/NL2011/050260
Other languages
English (en)
Inventor
Johannes VAN DER STEEN
Johannes Jacob Mient Pel
Original Assignee
Erasmus University Medical Center Rotterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus University Medical Center Rotterdam filed Critical Erasmus University Medical Center Rotterdam
Priority to PCT/NL2011/050260 priority Critical patent/WO2012141576A1/fr
Publication of WO2012141576A1 publication Critical patent/WO2012141576A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/02—Subjective types, i.e. testing apparatus requiring the active assistance of the patient
    • A61B3/024—Subjective types, i.e. testing apparatus requiring the active assistance of the patient for determining the visual field, e.g. perimeter types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/113—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining or recording eye movement

Definitions

  • the invention relates to a method for investigating visual field defects.
  • the invention further relates to a system for enabling investigating visual field defects.
  • the invention still further relates to a computer program for enabling investigating visual field defects.
  • Vision plays a prominent role in obtaining information from an environment. Humans continuously update visual information by making orienting eye movements. Eye movements can be voluntary, as during reading, or reflexive in response to a novel feature.
  • the first step in visual information processing is that the image of the visual world perceived is inverted and focussed by the lens and cornea of the eye onto the retina.
  • the retina is densely covered with photoreceptors that are intrinsically connected via a retinal neural network that locally processes and converts the incoming light into neural signals. These signals converge in the brain via ganglion cells nerve where it leaves the eye.
  • the integrity of the whole system of photoreceptors and neural networks of optic nerve fibres is crucial for processing contrast, colour and motion.
  • Impairments caused by either retinal (day/night sight, colour blindness) or optical nerve trauma (glaucoma, hemianopsia) have a large impact on the perception of the visual world.
  • a major problem is that loss of function in retina and/or optic nerve develops gradually over the course of many years.
  • Glaucoma is such an irreversible neurodegenerative disease that leads to visual field damage. Glaucoma develops unnoticed for a long time because the brain fills in the eventual gaps of the missing parts in the visual field.
  • glaucoma is the second leading cause of blindness.
  • a major cause for concern is that about 80 million people worldwide will be affected with glaucoma by the year 2020.
  • Population-based studies have shown that more than 90% of glaucoma cases in developing countries remain undiagnosed. These numbers are alarmingly high, although even in Western countries 40-60% of the population remains undiagnosed until late stage of the disease.
  • the progression of glaucoma can be slowed or halted when treatment is started at early stages of the disease, but the first symptoms are virtually undetectable without a detailed eye exam.
  • An embodiment of a method for carrying out a detailed eye exam is known from US 2010/0195051.
  • the method is adapted to use a suitable display for presenting a visual stimulus and an eye tracker for tracking movement of at least one patient's eye to determine its position in three dimensions. By tracking the position of the patient's eye in response to a given visual stimulus on the display, the eye's visual field angle may be determined.
  • the method according to the invention comprises the steps of:
  • the visual latency is defined as a saccadic reaction time to a new appearing visual stimulus that may differ in contrast.
  • stimuli are presented on a display screen, while a suitable monitoring device, such as a per se known eye tracker measures the gaze direction of the eye of the patient. If a shift in gaze corresponds to the location of a presented stimulus, the system indicates that a stimulus has been seen by the patient.
  • a suitable monitoring device such as a per se known eye tracker measures the gaze direction of the eye of the patient. If a shift in gaze corresponds to the location of a presented stimulus, the system indicates that a stimulus has been seen by the patient.
  • test does not require voluntary effort of the patient. Because eye movement responses are reflexive, this test is intuitive to the patient. It also allows precise measurement of eye movement reaction time or visual latency, which is found to be a reliable feature in glaucoma diagnosis.
  • the patient may be provided in front of a suitable electronic display, whereby his head is fixed. Then a number of different stimuli is provided in a visual field and the displacement of the eye is tracked and recorded. Visual latency is then calculated based on the measured velocity of the eye when following a visual stimulus. More details on calculation of the visual latency will be given with reference to Figure 2a, 2b and 2c.
  • the visual stimuli are provided in a randomized way in the selected visual field. More preferably, the contrast of the visual stimuli is randomized as well. It is found to be practical to select a visual field of +- 30 degrees in horizontal direction and +- 20 degrees in vertical direction from the eye's centre. In an embodiment of a method according to the invention data on the displacement of the patient's eye are used for determining the visual latency.
  • the visual stimuli are classified in accordance with a comparison between an actual measured eye velocity and a threshold value set for the measured eye velocity.
  • a relation between the calculated visual latency per stimulus and the coordinates of the stimulus is determined.
  • Such analysis enables determination of the blind spots in the visual field even for the symptom-less patient.
  • a graph is generated representing the relation between the calculated visual latency per stimulus and the coordinates of the stimulus.
  • a display arranged for providing a temporal sequence of distributed visual stimuli
  • a monitoring unit adapted for tracing a displacement of the patient's eye in response to the said sequence
  • a computer program product according to the invention comprises instructions for causing a processor to carry out the steps of the method as is discussed with reference to the foregoing.
  • Those skilled in the art of IT will readily appreciate which particular instructions may be used for embodying the computer program product according to the invention.
  • Figure 1 presents in a schematic way an embodiment of a sequence of stimuli as presented to the patient.
  • Figure 2a presents an embodiment of a gaze curve in relation to a peripheral stimulus.
  • Figure 2b presents an embodiment of a velocity curve corresponding to the gaze curve of Figure la.
  • Figure 2c presents an embodiment of an actual displacement of the eye according to the gaze curve of Figure 1.
  • Figure 3 presents an embodiment of a visual contrast map representing a blind-spot.
  • Figure 4 presents an embodiment of a visual latency map having a blind spot.
  • FIG. 5 presents in a schematic way an embodiment of a system according to an aspect of the invention.
  • Figure 1 presents in a schematic way an embodiment of a sequence of stimuli as presented to the patient.
  • an electronic display 2 may be used.
  • the electronic display 2 may be a commonly used computer monitor or any other suitable display.
  • the user is made conscious of a central point 4 on the display which is selected in correspondence with an AP-PA axis running through the centre of the patient's eye.
  • the patient will be requested to fix his eye at the central point 4 before gazing towards a stimulus of the type 3a, 3b, ... 3n when such stimulus will be provided.
  • the user may also be requested to return his eye back to the central point upon a certain dwell time fixed on the visual stimulus.
  • visual stimuli 3a, 3b, 3n are provided in sequence in a random way. Randomization of the position of the stimuli over the surface area of the display 2 is advantageous to prevent user's anticipation.
  • the stimuli 3a, 3b, 3n are of different contrast which respect to the background colour (usually grey or black) of the display 2.
  • the stimuli 31, 3b, 3n have shades of grey.
  • the visual stimuli may be provided at a frequency of 1 per 2 seconds, however, this frequency may be varied to prevent the patient from anticipating a stimulus leading to false
  • Figure 2a presents an embodiment of a gaze curve in relation to a peripheral stimulus.
  • the characteristic curve presented in Figure 2a is generated by correlating the position of the patient's eye by a suitable eye tracking module and by setting it off with respect to time lapsed.
  • the state of the art eye tracking systems are suitable for implementing the invention.
  • the eye tracking modules are based on infrared cameras adapted to track a position of the patient's pupil.
  • the initial dwelling D2 corresponds to the user glancing at the central point.
  • the user's eye will detect it and a reflexive movement towards a second dwell position Dl will be carried out.
  • the transition portion G corresponds to the actual gaze transition of the patient's eye.
  • Figure 2b presents an embodiment of a velocity curve corresponding to the gaze curve of Figure la. It will be appreciated that the curve of Figure 2b is obtained by differentiating the curve shown in Figure 1 over time. It is found to be advantageous to define a threshold, corresponding to noise seen in the data. Because the graph depicted in the Figure 2b represents the actual eye velocity, the threshold T may be referred to as a threshold eye velocity. In the particular example the threshold eye velocity is about 20 degrees/second. Accordingly, for an eye movement caused by a seen point on a display, a characteristic peak will occur.
  • the visual latency VL is defined as time calculated from the moment of presenting a visual stimulus to the eye until the eye deliberately moves towards the visual stimulus. It is found to be practical to set a suitable window characterizing the saccade (see vertical lines in the Figure 2b). The visual latency will be calculated then as time
  • the velocity curve as is depicted in Figure 2c may be used as a characteristic of the "seen” event.
  • the peripheral visual stimulus may be scored as “seen”. Accordingly, the measurements falling within the vertical frame schematically given by the vertical lines correspond to an event which is seen.
  • the visual field integrity can be on-line or off-line reconstructed from the locations of visual target labelled as "seen”.
  • Figure 3 shows an embodiment of the visual field integrity graph which is obtained on the basis of the minimum contrast of the "seen" targets to which an eye movement was made.
  • Figure 2c presents an embodiment of an actual displacement of the eye according to the gaze curve of Figure 1.
  • the gaze direction corresponding to a peripheral stimulus is illustrated.
  • the region C corresponds to a first dwelling, which may be pre-determined at the centre of the display.
  • any reference eye dwelling may be defined.
  • a visual stimulus S When a visual stimulus S is provided, the patient reacts to it in accordance to a reflex and a gaze movement is being made over the trajectory G.
  • the coordinates of the "seen" visual stimuli are being recorded for generating a visual field integrity graph, given in Figure 3.
  • Figure 3 presents an embodiment of a visual contrast map representing a blind-spot.
  • the visual field integrity map is scaled in accordance with the angular dimensions of the electronic display, discussed with reference to Figure 1.
  • two black areas Bl and B2 may be identified, which correspond to the areas of reduced responsiveness of the patient.
  • Figure 4 presents an embodiment of a visual latency map having a blind spot. This plot is obtained by analyzing the results of the Figure 3 together with the visual latency measurements data obtained for all stimuli presented to the patient.
  • the visual latency is a function which is dependent on the viewing angle, increasing towards the larger deviation angles. Therefore, the measured visual latency data may be corrected for the natural reduction of latency towards the periphery. Such correction may be carried out based on data collected for healthy population, preferably per age group. Alternatively, the measured data may be corrected using the individual patient's profile, which may be deduced from the actual patient's data, such as presented in the Figure 3, for example. Accordingly, an area corresponding to a substantially reduced or absent visual latency (area 41) may be identified.
  • the visual stimuli may be provided having a plurality of contrasts and intensities per measurement point. Threshold intensity is defined as a count of seen stimuli having the lowest contrast.
  • FIG. 5 presents in a schematic way an embodiment of a system according to an aspect of the invention.
  • the system 50 according to the invention comprises a support 56 for installing the patient's head 52 in an affixed position in front of en electronic display 57.
  • the display 57 is arranged to that a central portion thereof is positioned on an AP-PA axis A running through the centre of the patient's eye 54.
  • the system 50 is adapted to investigate visual field defects per eye.
  • the system 50 comprises a suitable eye tracking module 59 adapted to monitor the eye movement and to record corresponding data.
  • the eye tracker 59 may be controlled by a computer 60.
  • the computer 60 comprises a processor 61 arranged for calculating visual latency per visual stimulus present on the display 57 and forming part of a suitable sequence.
  • the processor 61 may also be arranged to control the display for generating stimuli with varied contrast.
  • the processor 61 may be further adapted to collect data from the eye tracker and to combine this data with the data on the coordinates of the generated visual stimuli for calculating visual latency. Based on the visual latency the stimuli may be classified by the processor as being "seen” or "not seen”. For the "seen” stimuli the processor may be further adapted to generate a map correlating a position of the stimuli and the visual latency. Preferably, such mapping is carried out for visual stimuli having lowest contrast.
  • the display 57 and the eye tracker 59 may be part of a virtual reality system, which may be embodied as a wearable helmet. It is found that a wearable helmet may be advantageous as the head movement with respect to the display is substantially avoided.
  • the operation of the system 50 may be controlled by a computer program product 62 which may be configured to comprise instructions for causing the processor 61 to carry out the steps of providing a temporal sequence of distributed visual stimuli; tracing data representative of a displacement of the patient's eye in response to the said sequence; calculating visual latency per visual stimulus present in the said sequence.
  • the computer program product may further comprise instructions for causing the processor to modulate the visual stimuli, for example to vary the contrast of the stimuli and the time between the stimuli.
  • the computer program product 62 may be further arranged to comprise instructions for causing the processor 61 to determine parameters as discussed with reference to Figures 2a, 2b, 2c and 3.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eye Examination Apparatus (AREA)

Abstract

L'invention concerne un procédé d'examen de défauts du champ de vision de l'œil d'un patient comprenant les étapes d'application d'une séquence temporelle de stimuli visuels distribués ; de tracé d'un déplacement de l'œil du patient en réponse à ladite séquence ; de calcul de la latence visuelle par stimulus visuel présent dans ladite séquence. L'invention concerne en outre un système pour permettre l'examen de défauts du champ visuel et un produit de programme informatique.
PCT/NL2011/050260 2011-04-15 2011-04-15 Procédé d'examen de défauts du champ de vision WO2012141576A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/NL2011/050260 WO2012141576A1 (fr) 2011-04-15 2011-04-15 Procédé d'examen de défauts du champ de vision

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2011/050260 WO2012141576A1 (fr) 2011-04-15 2011-04-15 Procédé d'examen de défauts du champ de vision

Publications (1)

Publication Number Publication Date
WO2012141576A1 true WO2012141576A1 (fr) 2012-10-18

Family

ID=44626061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2011/050260 WO2012141576A1 (fr) 2011-04-15 2011-04-15 Procédé d'examen de défauts du champ de vision

Country Status (1)

Country Link
WO (1) WO2012141576A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021096361A1 (fr) 2019-11-14 2021-05-20 Rijksuniversiteit Groningen Procédé, système, et produit-programme informatique pour cartographie d'un champ visuel

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3827789A (en) * 1971-01-08 1974-08-06 Biometrics Inc Monitoring devices
US4059348A (en) * 1974-09-12 1977-11-22 Narco Scientific Industries, Inc. Objective plotting of visual fields by eye movement monitoring
WO2004093668A1 (fr) * 2003-04-22 2004-11-04 John Andrew Murray Mcgrath Procede et appareil de diagnostic precoce et rapide du glaucome et d'autres troubles de la vue chez les humains et primates superieurs
WO2008139137A1 (fr) * 2007-05-16 2008-11-20 University Court Of The University Of Edinburgh Vérification du champ visuel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3827789A (en) * 1971-01-08 1974-08-06 Biometrics Inc Monitoring devices
US4059348A (en) * 1974-09-12 1977-11-22 Narco Scientific Industries, Inc. Objective plotting of visual fields by eye movement monitoring
WO2004093668A1 (fr) * 2003-04-22 2004-11-04 John Andrew Murray Mcgrath Procede et appareil de diagnostic precoce et rapide du glaucome et d'autres troubles de la vue chez les humains et primates superieurs
WO2008139137A1 (fr) * 2007-05-16 2008-11-20 University Court Of The University Of Edinburgh Vérification du champ visuel
US20100195051A1 (en) 2007-05-16 2010-08-05 University Court Of The University Of Edinburgh Testing Vision

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JERNIGAN ET AL: "Structural analysis of eye movement response to visual field stimuli", COMPUTERS IN BIOLOGY AND MEDICINE, NEW YORK, NY, US, vol. 10, no. 1, 1 January 1980 (1980-01-01), pages 11 - 22, XP022875363, ISSN: 0010-4825, [retrieved on 19800101], DOI: 10.1016/0010-4825(80)90003-7 *
KIM D E ET AL: "Eye movement perimetry", ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, 1995., IEEE 17TH ANNUAL C ONFERENCE MONTREAL, QUE., CANADA 20-23 SEPT. 1995, NEW YORK, NY, USA,IEEE, US, vol. 2, 20 September 1995 (1995-09-20), pages 1629 - 1630, XP010214959, ISBN: 978-0-7803-2475-6, DOI: 10.1109/IEMBS.1995.579863 *
MURRAY I C ET AL: "Feasibility of Saccadic Vector Optokinetic Perimetry", OPHTHALMOLOGY, J. B. LIPPINCOTT CO., PHILADELPHIA, PA, US, vol. 116, no. 10, 1 October 2009 (2009-10-01), pages 2017 - 2026, XP026666528, ISSN: 0161-6420, [retrieved on 20090627], DOI: 10.1016/J.OPHTHA.2009.03.015 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021096361A1 (fr) 2019-11-14 2021-05-20 Rijksuniversiteit Groningen Procédé, système, et produit-programme informatique pour cartographie d'un champ visuel

Similar Documents

Publication Publication Date Title
CN111511318B (zh) 数字治疗矫正眼镜
US11039745B2 (en) Vision defect determination and enhancement using a prediction model
US10802288B1 (en) Visual enhancement for dynamic vision defects
US10531795B1 (en) Vision defect determination via a dynamic eye-characteristic-based fixation point
CN101730500B (zh) 用于客观地测试视野的设备和方法
US9775512B1 (en) Binocular eye tracking from video frame sequences
US10742944B1 (en) Vision defect determination for facilitating modifications for vision defects related to double vision or dynamic aberrations
CN114025659A (zh) 眼睛的屈光不正确定
CN109634431B (zh) 无介质浮空投影视觉追踪互动系统
Tatler et al. Eye movement recordings in natural settings
WO2012141576A1 (fr) Procédé d'examen de défauts du champ de vision
JP2024525811A (ja) 複数の機能的な眼のパラメーターを決定するためのコンピュータープログラム、方法、及び装置
EP4262520B1 (fr) Procédé et dispositif pour déterminer une performance visuelle
JP2023501805A (ja) 視野マッピングのための方法、システムおよびコンピュータプログラム製品
CN115996664B (zh) 用于确定屈光不正的方法和设备
KR20230066101A (ko) 우세안의 정량화를 위한 시스템 및 방법
Buapong et al. A Low-Complexity and Efficient VR-Based System with Infrared Image Processing for Assessing the Angle of Ocular Misalignment in Strabismus Patients
Islam et al. BinoVFAR: An Efficient Binocular Visual Field Assessment Method using Augmented Reality Glasses
Penedo et al. Gaze behavior data in the vitrine of human movement science: considerations on eye-tracking technique
CN116725536A (zh) 一种眼动检查设备

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11717045

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11717045

Country of ref document: EP

Kind code of ref document: A1